1. Home
  2. ATAI vs GHI Comparison

ATAI vs GHI Comparison

Compare ATAI & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$3.52

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

GHI

Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

HOLD

Current Price

$5.40

Market Cap

173.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATAI
GHI
Founded
2018
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
173.3M
IPO Year
2021
1998

Fundamental Metrics

Financial Performance
Metric
ATAI
GHI
Price
$3.52
$5.40
Analyst Decision
Strong Buy
Buy
Analyst Count
7
3
Target Price
$15.57
$10.50
AVG Volume (30 Days)
4.7M
118.3K
Earning Date
03-06-2026
03-16-2026
Dividend Yield
N/A
22.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$308,000.00
$85,389,766.00
Revenue This Year
N/A
$296.72
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$5.30
52 Week High
$6.73
$13.10

Technical Indicators

Market Signals
Indicator
ATAI
GHI
Relative Strength Index (RSI) 42.79 19.41
Support Level $3.48 N/A
Resistance Level $4.30 $7.12
Average True Range (ATR) 0.21 0.36
MACD -0.03 -0.24
Stochastic Oscillator 13.85 4.23

Price Performance

Historical Comparison
ATAI
GHI

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.

Share on Social Networks: